Skip to main content

Formula Growth Ltd

SEC CIK
0001093219
Latest filing
Aug 17, 2026

TNDM holding history

Tandem Diabetes Care Inc in every 13F filed by Formula Growth Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TNDM overviewAll 13F holders of TNDMFull Q2 2026 holdings

Shares (Q2 2026)
70,304
Value
$1.06M
% of portfolio
0.4%
Quarters held
22
Since Q1 2021
Holdings of TNDM by Formula Growth Ltd, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202670,304$1.06M0.4%−524−0.7%ReducedHolders
Q1 202670,828$1.36M0.6%−91−0.1%ReducedHolders
Q4 202570,919$1.56M0.6%−51,177−41.9%ReducedHolders
Q3 2025122,096$1.48M0.5%00.0%UnchangedHolders
Q2 2025122,096$2.28M0.9%−1,849−1.5%ReducedHolders
Q1 2025123,945$2.37M1.0%−2,020−1.6%ReducedHolders
Q4 2024125,965$4.54M1.5%−2,160−1.7%ReducedHolders
Q3 2024128,125$5.43M1.9%+3,479+2.8%AddedHolders
Q2 2024124,646$5.02M1.8%+900+0.7%AddedHolders
Q1 2024123,746$4.38M1.4%+83,000+203.7%AddedHolders
Q4 202340,746$1.21M0.4%00.0%UnchangedHolders
Q3 202340,746$846.3K0.3%+17,000+71.6%AddedHolders
Q2 202323,746$582.7K0.2%00.0%UnchangedHolders
Q1 202323,746$964.3K0.3%−23,507−49.7%ReducedHolders
Q4 202247,253$2.12M0.6%+3,500+8.0%AddedHolders
Q3 202243,753$2.09M0.6%00.0%UnchangedHolders
Q2 202243,753$2.59M0.7%−5,000−10.3%ReducedHolders
Q1 202248,753$5.67M1.1%−3,676−7.0%ReducedHolders
Q4 202152,429$7.89M1.4%−3,556−6.4%ReducedHolders
Q3 202155,985$6.68M1.0%−9,000−13.8%ReducedHolders
Q2 202164,985$6.33M0.9%00.0%UnchangedHolders
Q1 202164,985$5.74M0.8%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.